Type your tag names separated by a space and hit enter

Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism

Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism ID - 451085 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451085/all/Once_versus_twice_daily_low_molecular_weight_heparin_for_the_initial_treatment_of_venous_thromboembolism PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -